Literature DB >> 11640966

Histamine reduces firing and bursting of anterior and intralaminar thalamic neurons and activates striatal cells in anesthetized rats.

N Sittig1, H Davidowa.   

Abstract

Histamine is known to play a role in the regulation of waking behavior as well as in processes of memory and reinforcement. The striatum and thalamic nuclei as the intralaminar complex and the anterior group can be involved in these functions. Little is known about the action of histamine on neurons of these brain structures. Single unit activity was extracellularly recorded in rats anesthetized with urethane. Firing of anterior and intralaminar thalamic neurons that responded to iontophoretically administered histamine was predominantly reduced (Wilcoxon test (Wt), P<0.05, n=49 and 63, respectively), whereas striatal neurons were mainly activated by the drug (Wt, P<0.05, n=29). Thalamic neurons also significantly reduced the number of burst discharges and the proportion of spikes involved in bursts. The histaminergic effects could be blocked by H1 or H2 receptor antagonists. In conclusion, histamine may control waking behavior also via nonspecific thalamic nuclei and basal ganglia circuits. Through modulation of the transmission in the anterior thalamus it may exert an influence on learning and emotional processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11640966     DOI: 10.1016/s0166-4328(01)00223-6

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  11 in total

1.  Histaminergic Control of Corticostriatal Synaptic Plasticity during Early Postnatal Development.

Authors:  Sungwon Han; Ricardo Márquez-Gómez; Myles Woodman; Tommas Ellender
Journal:  J Neurosci       Date:  2020-07-24       Impact factor: 6.167

2.  The wake-promoting transmitter histamine preferentially enhances α-4 subunit-containing GABAA receptors.

Authors:  Matt T Bianchi; Alison G Clark; Janet L Fisher
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

3.  Histamine modulates thalamocortical activity by activating a chloride conductance in ferret perigeniculate neurons.

Authors:  Kendall H Lee; Christian Broberger; Uhnoh Kim; David A McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

4.  Famotidine, a Histamine H2 Receptor Antagonist, Does Not Reduce Levodopa-Induced Dyskinesia in Parkinson's Disease: A Proof-of-Concept Study.

Authors:  Tiago A Mestre; Binit B Shah; Barbara S Connolly; Camila de Aquino; Amaal Al Dhakeel; Richard Walsh; Taneera Ghate; Jane P Lui; Susan H Fox
Journal:  Mov Disord Clin Pract       Date:  2014-06-26

5.  Histamine and motivation.

Authors:  Fernando Torrealba; Maria E Riveros; Marco Contreras; Jose L Valdes
Journal:  Front Syst Neurosci       Date:  2012-07-04

6.  Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats.

Authors:  Hongjuan Shi; Xinxin Yang; Hui Zhao; Shenyang Zhang; Jie Zu; Wei Zhang; Xia Shen; Guiyun Cui; Fang Hua; Chuanzhu Yan
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-27       Impact factor: 2.570

Review 7.  Histamine and the striatum.

Authors:  J Paul Bolam; Tommas J Ellender
Journal:  Neuropharmacology       Date:  2015-08-11       Impact factor: 5.250

Review 8.  Thalamic neuromodulation and its implications for executive networks.

Authors:  Carmen Varela
Journal:  Front Neural Circuits       Date:  2014-06-24       Impact factor: 3.492

9.  Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  Guiyun Cui; Xinxin Yang; Xiaoying Wang; Zunsheng Zhang; Xuanye Yue; Hongjuan Shi; Xia Shen
Journal:  Neuropsychiatr Dis Treat       Date:  2013-12-18       Impact factor: 2.570

Review 10.  The role of co-neurotransmitters in sleep and wake regulation.

Authors:  Jun Oh; Cathrine Petersen; Christine M Walsh; Jackson C Bittencourt; Thomas C Neylan; Lea T Grinberg
Journal:  Mol Psychiatry       Date:  2018-10-30       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.